Treatment of acute ischemic stroke: Selecting the right treatment for the right patient

European Neurology

Volumn 45, Issue 2, 2001, Pages 61-66

  Adams Jr , Harold P ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Acute stroke therapy; Stroke management; Thrombolysis

Indexed keywords

ALTEPLASE;

BLOOD CLOTTING; BRAIN BLOOD FLOW; BRAIN INJURY; CEREBROVASCULAR ACCIDENT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; DRUG EFFICACY; FIBRINOLYTIC THERAPY; HUMAN; NEUROLOGICAL COMPLICATION; NEUROPROTECTION; PRIORITY JOURNAL; REVIEW; TREATMENT INDICATION; TREATMENT OUTCOME;

ACUTE DISEASE; CEREBRAL INFARCTION; COMBINED MODALITY THERAPY; HUMANS; INTRACRANIAL EMBOLISM; RANDOMIZED CONTROLLED TRIALS; RECURRENCE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 0035105956     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000052097     Document Type: Review

References (21)

1. Tissue plasminogen activator for actue ischemic stroke
2. Thrombolysis in acute ischemic stroke: Controlled trials clinical experience
3. Tissue plasminogen activator for acute stroke in everyday clinical practice
4. Guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association
5. Is there still a role for intravenous heparin in acute stroke?
6. Guidelines for thrombolytic therapy for acute stroke: A supplement to the guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association
7. Practice advisory: Thrombolytic therapy for acute ischemic stroke - Summary statement. Report of the Quality Standards Subcommittee of the American Academy of Neurology
8. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II)
9. The ATLANTIS rt-PA (alteplase) Acute Stroke Trial. Final results
10. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: A randomized controlled trial
11. Defibrinogenation with Viprinex (ancrod) for the treatment of acute ischemic stroke
12. What have we learned from recent antiplatelet trials?
13. Collaborative systematic review of the randomised trials of organised inpatient (stroke unit) care after stroke
14. Issues answers in stroke care
15. Baseline NIH Stroke Scale score strongly predicts outcome after stroke. A report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST)
16. Generalized efficacy of t-PA for acute stroke. Subgroup analysis of the NINDS t-PA Stroke Trial
17. Cranial computed tomography interpretation in acute stroke: Physician accuracy in determining eligibility for thrombolytic therapy
18. New therapies for stroke
19. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment
20. Interphysician agreement in the diagnosis of subtypes of acute ischemic stroke: Implications for clinical trials
21. Accuracy of initial stroke subtype diagnosis in the TOAST study. Trial of O.R.G. 10172 in Acute Stroke Treatment